Hyperimmune globulin ‘fails to prevent congenital CMV infection’
Randomised controlled trial pours cold water on 'miracle cure', researcher says
Hyperimmune globulin therapy given to pregnant women with a cytomegalovirus (CMV) infection fails to protect their babies from congenital CMV infection or perinatal death, a study shows.
Congenital CMV infection is associated with stillbirth, neonatal death, deafness, and cognitive and motor delay among symptomatic offspring, the researchers note in their article in the New England Journal of Medicine.
